chartexchange

Cytek Biosciences Reports Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 4, 2026 4:05 PM EST

FREMONT, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2026.

Read original article